Nova Cannabis Stock Price To Earning
| NVACFDelisted Stock | USD 1.26 0.00 0.00% |
Nova Cannabis fundamentals help investors to digest information that contributes to Nova Cannabis' financial success or failures. It also enables traders to predict the movement of Nova OTC Stock. The fundamental analysis module provides a way to measure Nova Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Cannabis otc stock.
Nova |
Nova Cannabis OTC Stock Price To Earning Analysis
Nova Cannabis' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, Nova Cannabis has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Pharmaceutical Retailers (which currently averages 0.0) industry. The price to earning for all United States stocks is 100.0% higher than that of the company.
Nova Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Cannabis' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Nova Cannabis could also be used in its relative valuation, which is a method of valuing Nova Cannabis by comparing valuation metrics of similar companies.Nova Cannabis is currently under evaluation in price to earning category among its peers.
Nova Fundamentals
| Return On Equity | -0.2 | |||
| Return On Asset | -0.0287 | |||
| Profit Margin | (0.05) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | 59.13 M | |||
| Shares Outstanding | 57.15 M | |||
| Shares Owned By Insiders | 62.72 % | |||
| Shares Owned By Institutions | 5.20 % | |||
| Price To Book | 0.44 X | |||
| Price To Sales | 0.14 X | |||
| Revenue | 134.36 M | |||
| Gross Profit | 24.89 M | |||
| EBITDA | (7.32 M) | |||
| Net Income | (20.61 M) | |||
| Cash And Equivalents | 6.22 M | |||
| Cash Per Share | 0.11 X | |||
| Total Debt | 60.11 M | |||
| Debt To Equity | 1.11 % | |||
| Current Ratio | 1.07 X | |||
| Book Value Per Share | 0.92 X | |||
| Cash Flow From Operations | (9.98 M) | |||
| Earnings Per Share | (0.30) X | |||
| Number Of Employees | 548 | |||
| Market Capitalization | 35.92 M | |||
| Total Asset | 118.7 M | |||
| Z Score | 1.0 | |||
| Net Asset | 118.7 M |
About Nova Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Cannabis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Nova Cannabis information on this page should be used as a complementary analysis to other Nova Cannabis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Nova OTC Stock
If you are still planning to invest in Nova Cannabis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nova Cannabis' history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |